| DB ID | MyCo_3300 |
| Title | CXCR4+ granulocytes reflect fungal cystic fibrosis lung disease |
| Year | 2015 |
| PMID | 25929952 |
| Fungal Diseases involved | Fungal cystic fibrosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | This study was conducted in accordance with the amended Declaration of Helsinki. The local independent ethics committees (University of Tübingen, Tübingen, Germany and University of Munich, Munich, Germany) approved the protocol, and written informed consent was obtained from all patients. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Bronchoalveolar lavage fluid (BALF) |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | CXCR4+ |
| Biomarker Full Name | CXCR4+ |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Germany |
| Cohort | The cystic fibrosis group included 19 male and 21 female patients with a mean±SD age of 23±14 years. 10 subjects without pulmonary diseases were selected as the control group. |
| Cohort No. | 40 Patients and 10 control |
| Age Group | 23±14 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Analytic |
| Analysis Method | Flow Cytometry Analysis |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | Flow Cytometry Analysis |
| Up Regulation Down Regulation | Positive |
| Sequence Data | None |
| External Link | None |
